Drugs for Rheumatoid Arthritis: Global Markets to 2022
Report Scope:
This research report categorizes the drugs for rheumatoid arthritis market by type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.
Report Includes:
This research report categorizes the drugs for rheumatoid arthritis market by type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.
Report Includes:
- 95 data tables
- An overview of the global rheumatoid arthritis drugs market
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Identification of segments with high growth potential and their future applications
- Explanation of major drivers and regional dynamics of the market and current trends within the industry
- Detailed profiles of major vendors in the market, including AbbVie Inc., Amgen Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche AG and Pfizer Inc.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Currencies
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 DRUGS FOR RHEUMATOID ARTHRITIS MARKET CHARACTERISTICS
CHAPTER 4 DRUGS FOR RHEUMATOID ARTHRITIS MARKET SIZE AND GROWTH
Historic Market Growth
Drivers of the Market
Restraints on the Market
Forecast Market Growth
Drivers of the Market
Restraints on the Market
CHAPTER 5 DRUGS FOR RHEUMATOID ARTHRITIS MARKET TRENDS AND STRATEGIES
Increasing Use of Technology
3D PRINTING TECHNOLOGIES
Combo and Mono Therapy
New Applications of NSAIDS
CHAPTER 6 PESTLE ANALYSIS
Political
Government Financial Support
Uncertain Political Policies
Economic
Wealth
Globalization
Emerging Markets
Social
Ageing Global Population
Sedentary Lifestyles
Health Consciousness and Awareness
Traditional Medicine Continues to Pose Threat to Market
Technological
3D PRINTING TECHNOLOGIES
Internet Penetration and Mobile Applications
Legal
Stringent Regulations and Long Approval Procedures
Investment Regulations
Patent Issues
Government Intervention
Environmental
CHAPTER 7 DRUGS FOR RHEUMATOID ARTHRITIS MARKET SEGMENTATION
Global Drugs for Rheumatoid Arthritis Market, By Segment
Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
Disease Modifying Anti-Rheumatic Drugs (DMARDs)
Market Characteristics
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Market Characteristics
Corticosteroids
Market Characteristics
CHAPTER 8 DRUGS FOR RHEUMATOID ARTHRITIS MARKET REGIONAL AND COUNTRY ANALYSIS
Global Drugs for Rheumatoid Arthritis Market, By Region
Global Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Region
Global Drugs for Rheumatoid Arthritis Market Segmentation, By Region, 2017
Global Drugs for Rheumatoid Arthritis Market, By Country
Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Country
Global Drugs for Rheumatoid Arthritis Market Segmentation, 2017, By Country
CHAPTER 9 GLOBAL DRUGS FOR RHEUMATOID ARTHRITIS MARKET COMPARISON WITH MACRO ECONOMIC FACTORS
Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure
Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, By Country
CHAPTER 10 ASIA-PACIFIC DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Asia-Pacific Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Asia-Pacific Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Asia-Pacific Drugs for Rheumatoid Arthritis Market Forecast Market
Asia-Pacific Drugs for Rheumatoid Arthritis Market, By Segment
Asia-Pacific Drugs for Rheumatoid Arthritis Market, Historic and Forecast CAGR, By Segment
CHAPTER 11 ASIA-PACIFIC DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
China Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Taxes Levied
Corporate Tax Structure
Competitive Landscape
China Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
China Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
China Market Size, By Segment
China Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
India Drugs for Rheumatoid Arthritis Market Overview
Country Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
India Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
India Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
India Market Size, By Segment
India Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
Japan Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Japan Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Japan Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
Japan Market Size, By Segment
Japan Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
Australia Drugs for Rheumatoid Arthritis Market
Australia Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Australia Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
Australia Market Size, By Segment
Australia Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
CHAPTER 12 WESTERN EUROPE DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Western European Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Western Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Western Europe Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Western Europe Market Size, By Segment
Western Europe Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
CHAPTER 13 WESTERN EUROPE DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
UK Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
UK Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
UK Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
UK Market Size, By Segment
UK Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
Germany Drugs for Rheumatoid Arthritis Market
Germany Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Germany Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Germany Market Size, By Segment
Germany Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
France Drugs for Rheumatoid Arthritis Market
France Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
France Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
France Market Size, By Segment
France Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
Italy Drugs for Rheumatoid Arthritis Market
Italy Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Italy Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
Italy Market Size, By Segment
Italy Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
Spain Drugs for Rheumatoid Arthritis Market
Spain Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Spain Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Spain Market Size, By Segment
Spain Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
CHAPTER 14 EASTERN EUROPE DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Eastern European Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Eastern Europe Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Eastern Europe Market Size, By Segment
Eastern Europe Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
CHAPTER 15 EASTERN EUROPE DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
Russia Drugs for Rheumatoid Arthritis Market
Russia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Russia Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Russia Market Size, By Segment
Russia Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
CHAPTER 16 NORTH AMERICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET
North America Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Taxes Levied
Corporate Tax Structure
Competitive Landscape
North America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
North America Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
North America Market Size, By Segment
North America Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
CHAPTER 17 NORTH AMERICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
USA Drugs for Rheumatoid Arthritis Market
USA Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
USA Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
USA Market Size, By Segment
USA Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
CHAPTER 18 SOUTH AMERICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET
South America Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
South America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
South America Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
South America Market Size, By Segment
South America Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
CHAPTER 19 SOUTH AMERICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
Brazil Drugs for Rheumatoid Arthritis M
Brazil Drugs for Rheumatoid Arthritis Historic Market, 2013-2016
Brazil Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
Brazil Market Size, By Segment
Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
CHAPTER 20 MIDDLE EAST DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Middle Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Competitive Landscape
Middle East Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Middle East Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Middle East Market Size, By Segment
Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
CHAPTER 21 AFRICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Africa Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Regulations
Regulatory Bodies
Major Associations
Competitive Landscape
Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Africa Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Africa Market Size, By Segment
Africa Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
CHAPTER 22 DRUGS FOR RHEUMATOID ARTHRITIS MARKET CUSTOMER INFORMATION
Frequency of Pain after Treatment
Different Symptoms Experienced by Patients
Impact of Rheumatoid Arthritis at Workplace
Importance of Patient’s Role in the Management of Rheumatoid Arthritis
Capacity of Affordable Treatment
CHAPTER 23 DRUGS FOR RHEUMATOID ARTHRITIS MARKET COMPETITIVE LANDSCAPE
Company Profiles
ABBVIE INC.
AMGEN INC.
BRISTOL-MYERS SQUIBB COMPANY
F. HOFFMANN-LA ROCHE AG
PFIZER
CHAPTER 24 KEY MERGERS AND ACQUISITIONS IN THE DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Pfizer Acquired Hospira
Concordia Healthcare Acquired Covis Pharma Commercial Assets
Bristol-Myers Squibb Acquired Padlock Therapeutics
Alvotech Acquired Baliopharm
Atnahs Acquired Pharmaceutical Assets of F. Hoffmann-La Roche
CHAPTER 25 APPENDIX
Definitions of the Industry
Drugs for Rheumatoid Arthritis
Research Methodology
CHAPTER 26 REFERENCES
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Currencies
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 DRUGS FOR RHEUMATOID ARTHRITIS MARKET CHARACTERISTICS
CHAPTER 4 DRUGS FOR RHEUMATOID ARTHRITIS MARKET SIZE AND GROWTH
Historic Market Growth
Drivers of the Market
Restraints on the Market
Forecast Market Growth
Drivers of the Market
Restraints on the Market
CHAPTER 5 DRUGS FOR RHEUMATOID ARTHRITIS MARKET TRENDS AND STRATEGIES
Increasing Use of Technology
3D PRINTING TECHNOLOGIES
Combo and Mono Therapy
New Applications of NSAIDS
CHAPTER 6 PESTLE ANALYSIS
Political
Government Financial Support
Uncertain Political Policies
Economic
Wealth
Globalization
Emerging Markets
Social
Ageing Global Population
Sedentary Lifestyles
Health Consciousness and Awareness
Traditional Medicine Continues to Pose Threat to Market
Technological
3D PRINTING TECHNOLOGIES
Internet Penetration and Mobile Applications
Legal
Stringent Regulations and Long Approval Procedures
Investment Regulations
Patent Issues
Government Intervention
Environmental
CHAPTER 7 DRUGS FOR RHEUMATOID ARTHRITIS MARKET SEGMENTATION
Global Drugs for Rheumatoid Arthritis Market, By Segment
Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
Disease Modifying Anti-Rheumatic Drugs (DMARDs)
Market Characteristics
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Market Characteristics
Corticosteroids
Market Characteristics
CHAPTER 8 DRUGS FOR RHEUMATOID ARTHRITIS MARKET REGIONAL AND COUNTRY ANALYSIS
Global Drugs for Rheumatoid Arthritis Market, By Region
Global Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Region
Global Drugs for Rheumatoid Arthritis Market Segmentation, By Region, 2017
Global Drugs for Rheumatoid Arthritis Market, By Country
Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Country
Global Drugs for Rheumatoid Arthritis Market Segmentation, 2017, By Country
CHAPTER 9 GLOBAL DRUGS FOR RHEUMATOID ARTHRITIS MARKET COMPARISON WITH MACRO ECONOMIC FACTORS
Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure
Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, By Country
CHAPTER 10 ASIA-PACIFIC DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Asia-Pacific Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Asia-Pacific Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Asia-Pacific Drugs for Rheumatoid Arthritis Market Forecast Market
Asia-Pacific Drugs for Rheumatoid Arthritis Market, By Segment
Asia-Pacific Drugs for Rheumatoid Arthritis Market, Historic and Forecast CAGR, By Segment
CHAPTER 11 ASIA-PACIFIC DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
China Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Taxes Levied
Corporate Tax Structure
Competitive Landscape
China Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
China Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
China Market Size, By Segment
China Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
India Drugs for Rheumatoid Arthritis Market Overview
Country Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
India Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
India Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
India Market Size, By Segment
India Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
Japan Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Japan Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Japan Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
Japan Market Size, By Segment
Japan Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
Australia Drugs for Rheumatoid Arthritis Market
Australia Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Australia Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
Australia Market Size, By Segment
Australia Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
CHAPTER 12 WESTERN EUROPE DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Western European Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Western Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Western Europe Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Western Europe Market Size, By Segment
Western Europe Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
CHAPTER 13 WESTERN EUROPE DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
UK Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
UK Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
UK Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
UK Market Size, By Segment
UK Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
Germany Drugs for Rheumatoid Arthritis Market
Germany Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Germany Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Germany Market Size, By Segment
Germany Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
France Drugs for Rheumatoid Arthritis Market
France Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
France Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
France Market Size, By Segment
France Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
Italy Drugs for Rheumatoid Arthritis Market
Italy Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Italy Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
Italy Market Size, By Segment
Italy Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
Spain Drugs for Rheumatoid Arthritis Market
Spain Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
Spain Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Spain Market Size, By Segment
Spain Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
CHAPTER 14 EASTERN EUROPE DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Eastern European Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Eastern Europe Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Eastern Europe Market Size, By Segment
Eastern Europe Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
CHAPTER 15 EASTERN EUROPE DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
Russia Drugs for Rheumatoid Arthritis Market
Russia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Russia Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Russia Market Size, By Segment
Russia Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
CHAPTER 16 NORTH AMERICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET
North America Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Taxes Levied
Corporate Tax Structure
Competitive Landscape
North America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
North America Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
North America Market Size, By Segment
North America Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
CHAPTER 17 NORTH AMERICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
USA Drugs for Rheumatoid Arthritis Market
USA Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
USA Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
USA Market Size, By Segment
USA Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
CHAPTER 18 SOUTH AMERICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET
South America Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
South America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
South America Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
South America Market Size, By Segment
South America Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
CHAPTER 19 SOUTH AMERICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET: COUNTRY ANALYSIS
Brazil Drugs for Rheumatoid Arthritis M
Brazil Drugs for Rheumatoid Arthritis Historic Market, 2013-2016
Brazil Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
Brazil Market Size, By Segment
Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
CHAPTER 20 MIDDLE EAST DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Middle Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Major Contracts/ Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Competitive Landscape
Middle East Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Middle East Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Middle East Market Size, By Segment
Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
CHAPTER 21 AFRICA DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Africa Drugs for Rheumatoid Arthritis Market Overview
Region Information
Background Information
End User Customer Information
Government Initiatives
Regulations
Regulatory Bodies
Major Associations
Competitive Landscape
Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Africa Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
Africa Market Size, By Segment
Africa Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
CHAPTER 22 DRUGS FOR RHEUMATOID ARTHRITIS MARKET CUSTOMER INFORMATION
Frequency of Pain after Treatment
Different Symptoms Experienced by Patients
Impact of Rheumatoid Arthritis at Workplace
Importance of Patient’s Role in the Management of Rheumatoid Arthritis
Capacity of Affordable Treatment
CHAPTER 23 DRUGS FOR RHEUMATOID ARTHRITIS MARKET COMPETITIVE LANDSCAPE
Company Profiles
ABBVIE INC.
AMGEN INC.
BRISTOL-MYERS SQUIBB COMPANY
F. HOFFMANN-LA ROCHE AG
PFIZER
CHAPTER 24 KEY MERGERS AND ACQUISITIONS IN THE DRUGS FOR RHEUMATOID ARTHRITIS MARKET
Pfizer Acquired Hospira
Concordia Healthcare Acquired Covis Pharma Commercial Assets
Bristol-Myers Squibb Acquired Padlock Therapeutics
Alvotech Acquired Baliopharm
Atnahs Acquired Pharmaceutical Assets of F. Hoffmann-La Roche
CHAPTER 25 APPENDIX
Definitions of the Industry
Drugs for Rheumatoid Arthritis
Research Methodology
CHAPTER 26 REFERENCES
LIST OF TABLES
Summary Table: Global Drugs for Rheumatoid Arthritis Market, Through 2022
Table 1: Global Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 2: Global Drugs for Rheumatoid Arthritis Market, Through 2022
Table 3: Global Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 4: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 5: Global Drugs for Rheumatoid Arthritis Market, by Region, 2017
Table 6: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Region, Through 2022
Table 7: Global Drugs for Rheumatoid Arthritis Market Segmentation, by Region, 2017
Table 8: Global Drugs for Rheumatoid Arthritis Market, by Country, 2017
Table 9: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Country, 2013-2022
Table 10: Global Drugs for Rheumatoid Arthritis Market Segmentation, by Country, 2017
Table 11: Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, 2013-2022
Table 12: per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, by Country, 2017
Table 13: Asia-Pacific-Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 14: Asia-Pacific Drugs for Rheumatoid Arthritis Market, Through 2022
Table 15: Asia-Pacific Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 16: Asia-Pacific Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Table 17: China Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 18: China Drugs for Rheumatoid Arthritis Market, Through 2022
Table 19: China Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 20: China Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 21: India Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 22: India Drugs for Rheumatoid Arthritis Market, Through 2022
Table 23: India Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 24: India Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 25: Japan Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 26: Japan Drugs for Rheumatoid Arthritis Market, Through 2022
Table 27: Japan Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 28: Japan Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 29: Australia Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 30: Australia Drugs for Rheumatoid Arthritis Market, Through 2022
Table 31: Australia Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 32: Australia Drugs for Rheumatoid Arthritis Market Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 33: Western Europe Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 34: Western Europe Drugs for Rheumatoid Arthritis Market, Through 2022
Table 35: Western Europe Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 36: Western Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 37: UK Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 38: UK Drugs for Rheumatoid Arthritis Market, Through 2022
Table 39: UK Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 40: UK Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 41: Germany Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 42: Germany Drugs for Rheumatoid Arthritis Market, Through 2022
Table 43: Germany Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 44: Germany Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 45: France Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 46: France Drugs for Rheumatoid Arthritis Market, Through 2022
Table 47: France Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 48: France Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 49: Italy Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 50: Italy Drugs for Rheumatoid Arthritis Market, Through 2022
Table 51: Italy Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 52: Italy Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 53: Spain Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 54: Spain Drugs for Rheumatoid Arthritis Market, 2017-2022
Table 55: Spain Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 56: Spain Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 57: Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 58: Eastern Europe Drugs for Rheumatoid Arthritis Market, Through 2022
Table 59: Eastern Europe Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 60: Eastern Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 61: Russia Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 62: Russia Drugs for Rheumatoid Arthritis Market, Through 2022
Table 63: Russia Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 64: Russia Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 65: North America Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 66: North America Drugs for Rheumatoid Arthritis Market, Through 2022
Table 67: North America Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 68: North America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 69: USA Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 70: USA Drugs for Rheumatoid Arthritis Market, Through 2022
Table 71: USA Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 72: USA Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, Through 2022
Table 73: South America Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 74: South America Drugs for Rheumatoid Arthritis Market, Through 2022
Table 75: South America Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 76: South America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 77: Brazil Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 78: Brazil Drugs for Rheumatoid Arthritis Market, Through 2022
Table 79: Brazil Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 80: Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 81: Middle East Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 82: Middle East Drugs for Rheumatoid Arthritis Market, Through 2022
Table 83: Middle East Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 84: Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 85: Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Table 86: Africa Drugs for Rheumatoid Arthritis Market, Through 2022
Table 87: Africa Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 88: Africa Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 89: Global Market Shares for Key Competitors of Drugs for Rheumatoid Arthritis, 2017
Table 90: AbbVie Inc. Financial Performance, 2013 - 2017
Table 91: Amgen Inc. Financial Performance, 2013 – 2017
Table 92: Bristol-Myers Squibb Financial Performance, 2013 – 2017
Table 93: F. Hoffmann-La Roche Financial Performance, 2013 – 2017
Table 94: Pfizer Inc. Financial Performance, 2013 – 2017
Table 95: Market Data Sources
Summary Table: Global Drugs for Rheumatoid Arthritis Market, Through 2022
Table 1: Global Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 2: Global Drugs for Rheumatoid Arthritis Market, Through 2022
Table 3: Global Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 4: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 5: Global Drugs for Rheumatoid Arthritis Market, by Region, 2017
Table 6: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Region, Through 2022
Table 7: Global Drugs for Rheumatoid Arthritis Market Segmentation, by Region, 2017
Table 8: Global Drugs for Rheumatoid Arthritis Market, by Country, 2017
Table 9: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Country, 2013-2022
Table 10: Global Drugs for Rheumatoid Arthritis Market Segmentation, by Country, 2017
Table 11: Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, 2013-2022
Table 12: per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, by Country, 2017
Table 13: Asia-Pacific-Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 14: Asia-Pacific Drugs for Rheumatoid Arthritis Market, Through 2022
Table 15: Asia-Pacific Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 16: Asia-Pacific Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Table 17: China Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 18: China Drugs for Rheumatoid Arthritis Market, Through 2022
Table 19: China Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 20: China Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 21: India Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 22: India Drugs for Rheumatoid Arthritis Market, Through 2022
Table 23: India Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 24: India Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 25: Japan Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 26: Japan Drugs for Rheumatoid Arthritis Market, Through 2022
Table 27: Japan Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 28: Japan Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 29: Australia Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 30: Australia Drugs for Rheumatoid Arthritis Market, Through 2022
Table 31: Australia Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 32: Australia Drugs for Rheumatoid Arthritis Market Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 33: Western Europe Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 34: Western Europe Drugs for Rheumatoid Arthritis Market, Through 2022
Table 35: Western Europe Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 36: Western Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 37: UK Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 38: UK Drugs for Rheumatoid Arthritis Market, Through 2022
Table 39: UK Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 40: UK Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 41: Germany Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 42: Germany Drugs for Rheumatoid Arthritis Market, Through 2022
Table 43: Germany Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 44: Germany Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 45: France Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 46: France Drugs for Rheumatoid Arthritis Market, Through 2022
Table 47: France Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 48: France Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 49: Italy Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 50: Italy Drugs for Rheumatoid Arthritis Market, Through 2022
Table 51: Italy Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 52: Italy Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 53: Spain Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 54: Spain Drugs for Rheumatoid Arthritis Market, 2017-2022
Table 55: Spain Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 56: Spain Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 57: Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 58: Eastern Europe Drugs for Rheumatoid Arthritis Market, Through 2022
Table 59: Eastern Europe Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 60: Eastern Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 61: Russia Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 62: Russia Drugs for Rheumatoid Arthritis Market, Through 2022
Table 63: Russia Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 64: Russia Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 65: North America Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 66: North America Drugs for Rheumatoid Arthritis Market, Through 2022
Table 67: North America Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 68: North America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 69: USA Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 70: USA Drugs for Rheumatoid Arthritis Market, Through 2022
Table 71: USA Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 72: USA Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, Through 2022
Table 73: South America Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 74: South America Drugs for Rheumatoid Arthritis Market, Through 2022
Table 75: South America Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 76: South America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 77: Brazil Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 78: Brazil Drugs for Rheumatoid Arthritis Market, Through 2022
Table 79: Brazil Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 80: Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 81: Middle East Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 82: Middle East Drugs for Rheumatoid Arthritis Market, Through 2022
Table 83: Middle East Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 84: Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 85: Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Table 86: Africa Drugs for Rheumatoid Arthritis Market, Through 2022
Table 87: Africa Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 88: Africa Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 89: Global Market Shares for Key Competitors of Drugs for Rheumatoid Arthritis, 2017
Table 90: AbbVie Inc. Financial Performance, 2013 - 2017
Table 91: Amgen Inc. Financial Performance, 2013 – 2017
Table 92: Bristol-Myers Squibb Financial Performance, 2013 – 2017
Table 93: F. Hoffmann-La Roche Financial Performance, 2013 – 2017
Table 94: Pfizer Inc. Financial Performance, 2013 – 2017
Table 95: Market Data Sources
LIST OF FIGURES
Summary Figure: Global Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 1: Global Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 2: Global Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 3: PESTLE Analysis: Global drugs for rheumatoid arthritis market, 2017
Figure 4: Global Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 5: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 6: Global Drugs for Rheumatoid Arthritis Market Share, by Region, 2017
Figure 7: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Region, 2013-2022
Figure 8: Global Drugs for Rheumatoid Arthritis Market Segmentation, by Region, 2017
Figure 9: Global Drugs for Rheumatoid Arthritis Market Share, by Country, 2017
Figure 10: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Country, 2013-2022
Figure 11: Global Drugs for Rheumatoid Arthritis Market Segmentation, by Country, 2017
Figure 12: Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, 2013–2022
Figure 13: Asia-Pacific Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 14: Asia-Pacific Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 15: Asia-Pacific Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 16: Asia-Pacific Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 17: China Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 18: China Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 19: China Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 20: China Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 21: India Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 22: India Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 23: India Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 24: India Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 25: Japan Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 26: Japan Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 27: Japan Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 28: Japan Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market by Segment, 2013-2022
Figure 29: Australia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 30: Australia Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 31: Australia Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 32: Australia Drugs for Rheumatoid Arthritis Market Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 33: Western Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 34: Western Europe Drugs for Rheumatoid Arthritis market, 2017-2022
Figure 35: Western Europe Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 36: Western Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 37: UK Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 38: UK Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 39: UK Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 40: UK Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 41: Germany Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 42: Germany Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 43: Germany Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 44: Germany Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 45: France Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 46: France Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 47: France Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 48: France Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 49: Italy Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 50: Italy Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 51: Italy Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 52: Italy Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 53: Spain Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 54: Spain Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 55: Spain Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 56: Spain Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 57: Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 58: Eastern Europe Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 59: Eastern Europe Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 60: Eastern Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 61: Russia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 62: Russia Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 63: Russia Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 64: Russia Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 65: North America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 66: North America Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 67: North America Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 68: North America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 69: USA Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 70: USA Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 71: USA Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 72: USA Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 73: South America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 74: South America Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 75: South America Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 76: South America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 77: Brazil Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 78: Brazil Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 79: Brazil Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 80: Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 81: Middle East Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 82: Middle East Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 83: Middle East Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 84: Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 85: Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 86: Africa Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 87: Africa Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 88: Africa Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 89: Global Market Shares for Key Competitors of Drugs for Rheumatoid Arthritis, 2017
Figure 90: AbbVie Inc. Financial Performance, 2013-2017
Figure 91: Amgen Inc. Financial Performance, 2013-2017
Figure 92: Bristol-Myers Squibb Financial Performance, 2013-2017
Figure 93: F. Hoffmann-La Roche Financial Performance, 2013-2017
Figure 94: Pfizer Inc. Financial Performance, 2013-2017
Summary Figure: Global Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 1: Global Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 2: Global Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 3: PESTLE Analysis: Global drugs for rheumatoid arthritis market, 2017
Figure 4: Global Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 5: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 6: Global Drugs for Rheumatoid Arthritis Market Share, by Region, 2017
Figure 7: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Region, 2013-2022
Figure 8: Global Drugs for Rheumatoid Arthritis Market Segmentation, by Region, 2017
Figure 9: Global Drugs for Rheumatoid Arthritis Market Share, by Country, 2017
Figure 10: Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Country, 2013-2022
Figure 11: Global Drugs for Rheumatoid Arthritis Market Segmentation, by Country, 2017
Figure 12: Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, 2013–2022
Figure 13: Asia-Pacific Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 14: Asia-Pacific Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 15: Asia-Pacific Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 16: Asia-Pacific Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 17: China Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 18: China Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 19: China Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 20: China Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 21: India Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 22: India Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 23: India Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 24: India Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 25: Japan Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 26: Japan Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 27: Japan Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 28: Japan Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market by Segment, 2013-2022
Figure 29: Australia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 30: Australia Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 31: Australia Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 32: Australia Drugs for Rheumatoid Arthritis Market Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 33: Western Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 34: Western Europe Drugs for Rheumatoid Arthritis market, 2017-2022
Figure 35: Western Europe Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 36: Western Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 37: UK Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 38: UK Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 39: UK Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 40: UK Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 41: Germany Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 42: Germany Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 43: Germany Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 44: Germany Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 45: France Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 46: France Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 47: France Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 48: France Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 49: Italy Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 50: Italy Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 51: Italy Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 52: Italy Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 53: Spain Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 54: Spain Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 55: Spain Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 56: Spain Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 57: Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 58: Eastern Europe Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 59: Eastern Europe Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 60: Eastern Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 61: Russia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 62: Russia Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 63: Russia Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 64: Russia Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 65: North America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 66: North America Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 67: North America Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 68: North America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 69: USA Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 70: USA Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 71: USA Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 72: USA Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 73: South America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 74: South America Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 75: South America Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 76: South America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 77: Brazil Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 78: Brazil Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 79: Brazil Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 80: Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 81: Middle East Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 82: Middle East Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 83: Middle East Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 84: Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 85: Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 86: Africa Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 87: Africa Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 88: Africa Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 89: Global Market Shares for Key Competitors of Drugs for Rheumatoid Arthritis, 2017
Figure 90: AbbVie Inc. Financial Performance, 2013-2017
Figure 91: Amgen Inc. Financial Performance, 2013-2017
Figure 92: Bristol-Myers Squibb Financial Performance, 2013-2017
Figure 93: F. Hoffmann-La Roche Financial Performance, 2013-2017
Figure 94: Pfizer Inc. Financial Performance, 2013-2017
